Current Ratio in % of Cogent Biosciences, Inc. from Q3 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Cogent Biosciences, Inc. quarterly Current Ratio history and change rate from Q3 2018 to Q3 2025.
  • Cogent Biosciences, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 528 %, a 37.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Cogent Biosciences, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 528 -320 -37.8% 30 Sep 2025
Q2 2025 525 -390 -42.7% 30 Jun 2025
Q1 2025 637 -349 -35.4% 31 Mar 2025
Q4 2024 782 -151 -16.2% 31 Dec 2024
Q3 2024 848 -177 -17.3% 30 Sep 2024
Q2 2024 915 -239 -20.7% 30 Jun 2024
Q1 2024 985 -142 -12.6% 31 Mar 2024
Q4 2023 933 -200 -17.6% 31 Dec 2023
Q3 2023 1.03K -187 -15.4% 30 Sep 2023
Q2 2023 1.15K -51 -4.24% 30 Jun 2023
Q1 2023 1.13K -167 -12.9% 31 Mar 2023
Q4 2022 1.13K -453 -28.6% 31 Dec 2022
Q3 2022 1.21K -539 -30.8% 30 Sep 2022
Q2 2022 1.2K -304 -20.1% 30 Jun 2022
Q1 2022 1.29K +19.3 +1.51% 31 Mar 2022
Q4 2021 1.59K +732 +85.6% 31 Dec 2021
Q3 2021 1.75K +1.3K +289% 30 Sep 2021
Q2 2021 1.51K +1.25K +479% 30 Jun 2021
Q1 2021 1.28K +1.03K +410% 31 Mar 2021
Q4 2020 854 +609 +248% 31 Dec 2020
Q3 2020 450 +193 +74.9% 30 Sep 2020
Q2 2020 260 -32.9 -11.2% 30 Jun 2020
Q1 2020 250 -79 -24% 31 Mar 2020
Q4 2019 246 -59.8 -19.6% 31 Dec 2019
Q3 2019 257 -52.2 -16.9% 30 Sep 2019
Q2 2019 293 30 Jun 2019
Q1 2019 329 31 Mar 2019
Q4 2018 306 31 Dec 2018
Q3 2018 310 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.